Hot and Cold Therapy Packs - Global Strategic Business

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Hot and Cold Therapy Packs - Global Strategic Business Report 2015 - 2020

Dublin, Dec. 09, 2015 (GLOBE NEWSWIRE) -- Research and Markets ( http://www.researchandmarkets.com/research/l3...t_and_cold ) has announced the addition of the "Hot and Cold Therapy Packs - Global Strategic Business Report" report to their offering. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs.

This report analyzes the worldwide markets for Hot and Cold Therapy Packs in US$ Thousand by the following Product Segments: Cold Packs, Hot Packs, Moist Therapy Packs, and Localized Heating/Cooling Pads.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. The report profiles 87 companies including many key and niche players such as

  • 3M Company (US)
  • Beiersdorf Australia Limited (Australia)
  • BREG, Inc. (US)
  • Bruder Healthcare Company (US)
  • Caldera International, Inc. (US)
  • Cardinal Health, Inc. (US)
  • Carex Health Brands (US)
  • Core Products International, Inc. (US)
  • DJO Global, Inc. (US)
  • Halyard Health, Inc. (US)
  • Kobayashi Pharmaceutical Co., Ltd. (Japan)
  • Koolpak Ltd (UK)
  • Medichill (Australia)
  • Medline Industries, Inc. (US)
  • Medtronic plc (Ireland)
  • Modular Thermal Technologies, Inc. (US)
  • Pfizer Incorporated (US)
  • The Mentholatum Company (US)
  • THERA°PEARL, LLC (US)

Key Topics Covered: 1. MARKET OVERVIEW 2. MARKET TRENDS & DRIVERS 3. PRODUCT OVERVIEW 4. THERMOTHERAPY AND CRYOTHERAPY: A MACRO PERSPECTIVE 5. PRODUCT INTRODUCTIONS/INNOVATIONS 6. RECENT INDUSTRY ACTIVITY 7. FOCUS ON SELECT PLAYERS 8. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 87 (including Divisions/Subsidiaries - 95)

  • The United States (72)
  • Canada (4)
  • Japan (1)
  • Europe (12)
  • - Germany (5)
  • - The United Kingdom (5)
  • - Italy (1)
  • - Rest of Europe (2)
  • Asia-Pacific (Excluding Japan) (5)

For more information visit http://www.researchandmarkets.com/research/l3...t_and_cold

CONTACT: Research and Markets Laura Wood, Senior Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Medical Devices

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Oscar Health Options Activity and Market Insights for Investors

Updated Category News Views 265

Understanding Oscar Health's Recent Options Activity In the fast-paced world of trading, Oscar Health Inc’s (NYSE: OSCR) recent options activity has captured significant attention among savvy investors. Notably, there has been a notable bullish sentiment from wealthy investors towards this health insurance company. Tracking public options data reveals movements that...

Continue Reading
Better Choice Company Finalizes Sale of Halo Asia Business

Updated Category News Views 160

Better Choice Company Settles on Halo Asia Sale Better Choice Company, Inc. (BTTR), a leader in pet health and wellness, has recently reached a significant milestone by signing a definitive agreement to sell its Halo business in Asia. This sale is projected to generate total gross proceeds of $8.1 million, which encompasses $6.5 million in cash at the closing of the deal....

Continue Reading
Fastenal Prepares for Earnings Report: What Investors Should Know

Updated Category News Views 154

Fastenal Prepares for Earnings Report Fastenal (NASDAQ: FAST) is gearing up to release its quarterly earnings report. Investors are keenly anticipating the upcoming announcement, as it offers a glimpse into the company's financial performance. This article provides essential insights and analysis for those eager to understand what to expect from Fastenal's announcement....

Continue Reading
Compass Therapeutics Takes Major Steps in Biliary Cancer Trials

Updated Category News Views 203

Compass Therapeutics Advances Cancer Research BOSTON — Compass Therapeutics, Inc. (Nasdaq: CMPX), a promising player in the biotechnology sphere focused on developing innovative therapies for cancer, has made significant strides in its clinical research. The company has announced that the first patient has been dosed in a groundbreaking Investigator Sponsored Trial...

Continue Reading
Understanding the Recent ECB Fine on LHV Group and Its Implications

Updated Category News Views 218

Overview of the ECB Fine Imposed on LHV Group The European Central Bank (ECB) has recently informed AS LHV Group about a decision to levy an administrative fine amounting to EUR 405 thousand. This fine is linked to an error identified in the consolidated regulatory reporting for a specified timeframe. The issue arose from discrepancies in how the equity of LHV Bank...

Continue Reading